DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Jiang Sheng - 1 It's - 1 Ted Alexander - 1 CNBC's - 1 David Tepper - 1 Michael Burry - 1 Alibaba - 1 Tepper - 1
Top related locs:
China Beijing Wall Japan South Korea Singapore Europe Greater China
Top related orgs:
Visual China - 1 Getty - 1 Appaloosa Management - 1 KE Holdings - 1 Baidu - 1 BCA Research - 1 K2 Asset Management - 1 CNBC - 1

Search resuls for: "China's Ministry of Transport"


4 mentions found


☆ Big names like David Tepper and 'Big Short' investor Michael Burry are quietly upping their bets on the Chinese economy
  + stars: | 2024-09-17 | by ( Zahra Tayeb | ) www.cnbc.com   time to read: +5 min
From property woes to sluggish economic data, China appears to be suffering from long Covid. Wall Street turns bullishBillionaire investors, including Appaloosa Management founder David Tepper and "Big Short" investor Michael Burry, recently revealed they are sticking to their China bets. The famed investor loaded up on Alibaba stock in the second quarter, revealing an $11.2 million position in the company. That makes Alibaba Burry's largest holding, with other Chinese tech stocks including Baidu and JD.com also featuring on Burry's portfolio. Meanwhile, BCA Research recently upgraded Chinese onshore stocks to overweight, with China strategist Jing Sima expecting Chinese onshore stocks to passively outperform global equities.
Persons: Jiang Sheng, It's, Ted Alexander, CNBC's, David Tepper, Michael Burry, Alibaba, Tepper, Burry, JD.com, Jing Sima, George Boubouras, Goldman Sachs, Song Zhiyong, Eric Lin Organizations: Visual China, Getty, Appaloosa Management, KE Holdings, Baidu, BCA Research, K2 Asset Management, CNBC, Bank of America, National Bureau of Statistics, China's Ministry of Transport, Civil Aviation Administration, Asia Pacific Summit for Aviation Safety, Paris Olympic Games, Greater, Greater China Research, UBS Locations: China, Beijing, Wall, Japan, South Korea, Singapore, Europe, Greater China
☆ China's big consumer market isn't rebounding to pre-pandemic levels just yet
  + stars: | 2023-01-09 | by ( Evelyn Cheng | ) www.cnbc.com   time to read: +5 min
For the past six months, revenue had dropped to 30% of typical levels, Chong said. The travel season for China's big holiday runs this year from around Jan. 7 to Feb. 15. That's twice what it was last year, and 70% of 2019 levels, China's Ministry of Transport said Friday. It noted most of the trips will likely be for visiting family, while just 10% will be for leisure or business travel. By that time, people will have been able to process their passport applications, while the number of international flights may have recovered to 50% or 60% of 2019 levels, Chen said.
☆ China's 'great migration' kicks-off under shadow of COVID
  + stars: | 2023-01-07 | by ( Casey Hall | ) www.reuters.com   time to read: +6 min
BORDER REOPENINGSunday marks the reopening of China's border with Hong Kong and the end of China's requirement for inbound international travellers to quarantine. More than a dozen countries are now demanding COVID tests from Chinese travellers, as the World Health Organisation said China's official virus data underreported the true extent of its outbreak. In Shanghai, for example, the city government on Friday announced an end to free PCR tests for residents from Jan. 8. China has relied on nine domestically-developed COVID vaccines approved for use, including inactivated vaccines, but none have been adapted to target the highly-transmissible Omicron variant and its offshoots currently in circulation. China reported three new COVID deaths in the mainland for Friday, bringing its official virus death toll to 5,267, one of the lowest in the world.
☆ China cracks down on drug price gouging amid fears of COVID spike
  + stars: | 2022-12-10 | by ( ) www.reuters.com   time to read: +2 min
China announced 10 measures on Wednesday that loosened key parts of President Xi Jinping's signature zero-COVID policy, in a dramatic pivot toward economic reopening. But concerns are increasing of a spike in infections as people scramble for cough medicines, flu drugs and masks. China's State Administration for Market Regulation admonished against price gouging in anti-COVID products, citing the need to better protect human lives and health. In a warning letter posted on Friday, the watchdog banned activities including price inflation, collusion, price discrimination, misleading propaganda and hoarding. In addition, they must not hoard anti-pandemic supplies that are in short supply, or spread word of price hikes to disrupt market order, the watchdog said.
0 next >>
Total: 4